Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
Baxter
Moodys
Johnson and Johnson

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Synthelabo v. Apotex Inc. (S.D.N.Y. 2002)

See Plans and Pricing

« Back to Dashboard

Sanofi-Synthelabo v. Apotex Inc. (S.D.N.Y. 2002)

Docket   Start Trial Date Filed 2002-03-21
Court District Court, S.D. New York Date Terminated 2010-10-19
Cause 35:271 Patent Infringement Assigned To Sidney H. Stein
Jury Demand Plaintiff Referred To
Parties APOTEX CORP.; APOTEX INC.; BRISTOL-MYERS SQUIBB COMPANY; BRISTOL-MYERS SQUIBB SANOFI PHARMACEUTICALS HOLDING PARTNERSHIP; DR. ANDREW G. BODNAR; DR. REDDY'S LABORATORIES, INC.; DR. REDDY'S LABORATORIES, LTD.; NATIONAL ASSOCIATION OF CHAIN DRUG STORES; SANOFI-AVENTIS; SANOFI-SYNTHELABO; SANOFI-SYNTHELABO INC.
Patents 4,529,596; 4,847,265; 5,576,328; 5,641,803; 5,670,537; 6,150,365
Attorneys Anthony F Lo Cicero; Bruce J. Chasan; Evan R Chesler; Jonathan Jay Faust; Lawrence S. Bader; Mona Gupta; Richard J Stark; Robert Louis Baechtold; Robert S. Silver; Thomas H. Beck; Zachary R. Davis
Firms Hangley Aronchick Segal & Pudlin; Morvillo Abramowitz Grand Iason Anello & Bohrer, P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Sanofi-Synthelabo v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Sanofi-Synthelabo v. Apotex Inc. (S.D.N.Y. 2002)

Date Filed Document No. Description Snippet Link To Document
2005-10-18 189 Reply CONSTRUCTION OF CLAIMS 1,2,8, 11 AND 12 of U.S. Patent 4,529,596. Document filed by Apotex Inc., Apotex Corp…2002 19 October 2010 1:02-cv-02255-SHS Patent Plaintiff District Court, S.D External link to document
2005-10-31 190 Response Construction of Claims 1,2,8,11 and 12 of U.S. Patent No. 4,529,596 (Apotex Motion NO. 32). Document filed by…2002 19 October 2010 1:02-cv-02255-SHS Patent Plaintiff District Court, S.D External link to document
2006-08-17 266 Exhibit A - E litigations between them involving U.S. Patent No. 4,847,265, 02CV-2255 and 05CV-3965, on the following… litigations between them involving U.S. Patent No, 4,847,265, 02CV-2255 and 05CV-3965, on the following…Evaluations.” W. “Patent Infiingement” means infringement of any patent or of any filed patent application,…reexamination, patent term restoration, or patents of addition and extensions thereof X. “Patent Infringement… EE. “Taxol Patent” means one or more of (i) U.S. Patent No. 5,670,537, (ii) U.S. Patent No. 5,641,803 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
McKinsey
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.